These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 14984373)

  • 21. Otilonium bromide in irritable bowel syndrome: a double-blind, placebo-controlled, 15-week study.
    Battaglia G; Morselli-Labate AM; Camarri E; Francavilla A; De Marco F; Mastropaolo G; Naccarato R
    Aliment Pharmacol Ther; 1998 Oct; 12(10):1003-10. PubMed ID: 9798806
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Standardized herbal treatments on functional bowel disorders: moving from putative mechanisms of action to controlled clinical trials.
    Cremonini F
    Neurogastroenterol Motil; 2014 Jul; 26(7):893-900. PubMed ID: 24965903
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A double-blind, randomized, placebo-controlled dose-ranging study to evaluate the efficacy of alosetron in the treatment of irritable bowel syndrome.
    Bardhan KD; Bodemar G; Geldof H; Schütz E; Heath A; Mills JG; Jacques LA
    Aliment Pharmacol Ther; 2000 Jan; 14(1):23-34. PubMed ID: 10632642
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Peppermint oil (Mintoil) in the treatment of irritable bowel syndrome: a prospective double blind placebo-controlled randomized trial.
    Cappello G; Spezzaferro M; Grossi L; Manzoli L; Marzio L
    Dig Liver Dis; 2007 Jun; 39(6):530-6. PubMed ID: 17420159
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of alosetron on responses to colonic distension in patients with irritable bowel syndrome.
    Delvaux M; Louvel D; Mamet JP; Campos-Oriola R; Frexinos J
    Aliment Pharmacol Ther; 1998 Sep; 12(9):849-55. PubMed ID: 9768527
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Improvement in pain and bowel function in female irritable bowel patients with alosetron, a 5-HT3 receptor antagonist.
    Camilleri M; Mayer EA; Drossman DA; Heath A; Dukes GE; McSorley D; Kong S; Mangel AW; Northcutt AR
    Aliment Pharmacol Ther; 1999 Sep; 13(9):1149-59. PubMed ID: 10468696
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Therapeutic Effect of Chang'an I Recipe ( I ) on Irritable Bowel Syndrome with Diarrhea: A Multicenter Randomized Double-Blind Placebo-Controlled Clinical Trial.
    Tang XD; Lu B; Li ZH; Wei W; Meng LN; Li BS; Tang ZP; Gao R; Wang FY; Lu F; Bian LQ; Zhao YP; Wang P; Zhang YQ
    Chin J Integr Med; 2018 Sep; 24(9):645-652. PubMed ID: 27487786
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of irritable bowel syndrome with Chinese herbal medicine: a randomized controlled trial.
    Bensoussan A; Talley NJ; Hing M; Menzies R; Guo A; Ngu M
    JAMA; 1998 Nov; 280(18):1585-9. PubMed ID: 9820260
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Randomized, double-blind, placebo-controlled trial of prednisolone in post-infectious irritable bowel syndrome.
    Dunlop SP; Jenkins D; Neal KR; Naesdal J; Borgaonker M; Collins SM; Spiller RC
    Aliment Pharmacol Ther; 2003 Jul; 18(1):77-84. PubMed ID: 12848628
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of Open-label Placebo on Children and Adolescents With Functional Abdominal Pain or Irritable Bowel Syndrome: A Randomized Clinical Trial.
    Nurko S; Saps M; Kossowsky J; Zion SR; Di Lorenzo C; Vaz K; Hawthorne K; Wu R; Ciciora S; Rosen JM; Kaptchuk TJ; Kelley JM
    JAMA Pediatr; 2022 Apr; 176(4):349-356. PubMed ID: 35099543
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel treatment for constipation-predominant irritable bowel syndrome using Padma Lax, a Tibetan herbal formula.
    Sallon S; Ben-Arye E; Davidson R; Shapiro H; Ginsberg G; Ligumsky M
    Digestion; 2002; 65(3):161-71. PubMed ID: 12138321
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Double-blind study of the effect of cisapride on constipation and abdominal discomfort as components of the irritable bowel syndrome.
    Schütze K; Brandstätter G; Dragosics B; Judmaier G; Hentschel E
    Aliment Pharmacol Ther; 1997 Apr; 11(2):387-94. PubMed ID: 9146780
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of diarrhea-predominant irritable bowel syndrome with traditional Chinese herbal medicine: a randomized placebo-controlled trial.
    Leung WK; Wu JC; Liang SM; Chan LS; Chan FK; Xie H; Fung SS; Hui AJ; Wong VW; Che CT; Sung JJ
    Am J Gastroenterol; 2006 Jul; 101(7):1574-80. PubMed ID: 16863563
    [TBL] [Abstract][Full Text] [Related]  

  • 34. STW 5, a phytopharmacon for patients with functional dyspepsia: results of a multicenter, placebo-controlled double-blind study.
    von Arnim U; Peitz U; Vinson B; Gundermann KJ; Malfertheiner P
    Am J Gastroenterol; 2007 Jun; 102(6):1268-75. PubMed ID: 17531013
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A randomized, double-blind, placebo-controlled trial of St John's wort for treating irritable bowel syndrome.
    Saito YA; Rey E; Almazar-Elder AE; Harmsen WS; Zinsmeister AR; Locke GR; Talley NJ
    Am J Gastroenterol; 2010 Jan; 105(1):170-7. PubMed ID: 19809408
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-inflammatory and tight junction protective activity of the herbal preparation STW 5-II on mouse intestinal organoids.
    Elbadawi M; Ammar RM; Aziz-Kalbhenn H; Rabini S; Klauck SM; Dawood M; Saeed MEM; Kampf CJ; Efferth T
    Phytomedicine; 2021 Jul; 88():153589. PubMed ID: 34111617
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A randomized, double-blind, placebo-controlled trial of tegaserod in female patients suffering from irritable bowel syndrome with constipation.
    Novick J; Miner P; Krause R; Glebas K; Bliesath H; Ligozio G; Rüegg P; Lefkowitz M
    Aliment Pharmacol Ther; 2002 Nov; 16(11):1877-88. PubMed ID: 12390096
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modulation of Intestinal Corticotropin-Releasing Hormone Signaling by the Herbal Preparation STW 5-II: Possible Mechanisms for Irritable Bowel Syndrome Management.
    Elbadawi M; Ammar RM; Rabini S; Klauck SM; Efferth T
    Pharmaceuticals (Basel); 2022 Sep; 15(9):. PubMed ID: 36145342
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Dinggui Oil Capsule in treating irritable bowel syndrome with stagnation of qi and cold: a prospective, multi-center, randomized, placebo-controlled, double-blind trial].
    Zhang RM; Wang L; Yang XN; Xia Q; Jiang MD; Fan ZJ; Zhang FX; Zhang HR; Yu Z; Li TQ
    Zhong Xi Yi Jie He Xue Bao; 2007 Jul; 5(4):392-7. PubMed ID: 17631801
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Herbal Preparation STW 5 for Functional Gastrointestinal Disorders: Clinical Experience in Everyday Practice.
    Lapina TL; Trukhmanov AS
    Dig Dis; 2017; 35 Suppl 1():30-35. PubMed ID: 29421814
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.